The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved Wainzua (eplontersen) to treat adults with ...
Pharmaceutical Technology on MSN2d
US uncertainty weighs on IPO market while UK innovation could benefitPanellists at the OBN BioTrinity 2025 conference in London discussed how US uncertainty is impacting the biopharma ...
News Medical on MSN2d
4basebio receives MHRA GMP licence for manufacture and supply of synthetic DNAPLC (AIM: 4BB) (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced that it has received ...
The MHRA has introduced seven new CERSIs to modernise healthcare regulation and accelerate patient access to innovative ...
News Medical on MSN8d
Testing for just three genes could help prevent 75% of avoidable side effects for certain medicationsA new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the ...
As with all products, the MHRA will keep its safety under close review. Prostate cancer is one of the most common cancers in ...
Saint Herblain (France), March 31, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted a label extension application to the ...
CHMP recommends approval for XOANACYL, an oral therapy for use in the following therapeutic areas: Iron deficiency, chronic renal failure and ...
4basebio PLC has been granted Good Manufacturing Practice (GMP) certification by the UK’s Medicines and Healthcare products ...
A new study from Queen Mary University of London found that 9% of all reported adverse drug reactions (ADRs) reported to the UK medicines regulator are associated with medications where side effect ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback